These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 8060151)

  • 1. [Quantitative assay of growth response of clinical breast cancer cells against E2 or E2-conjugated drugs].
    Matsuoka H; Furusawa M; Sugimachi K
    Gan To Kagaku Ryoho; 1994 Aug; 21(10):1705-6. PubMed ID: 8060151
    [No Abstract]   [Full Text] [Related]  

  • 2. Growth inhibitory effect of estrogen conjugated drugs against primary cultured breast cancer cells.
    Matsuoka H; Sugimachi K; Tomoda H; Saito T; Seo Y
    Anticancer Res; 1995; 15(4):1289-96. PubMed ID: 7654011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth-inhibitory action of an estrogen-chlorambucil conjugate (KM2210) in human breast cancer cell line MCF-7: its relation to reduction of estrogen receptor and transforming growth factor-alpha secretion.
    Kosano H; Kubota T; Ohsawa N; Yamamori S; Abe O; Inagaki H; Nagata N
    Cancer Res; 1992 Mar; 52(5):1187-91. PubMed ID: 1737378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale for sequential tamoxifen and anticancer drugs in adjuvant setting for patients with node- and receptor-positive breast cancer.
    Kim R; Tanabe K; Emi M; Uchida Y; Osaki A; Toge T
    Int J Oncol; 2005 Apr; 26(4):1025-31. PubMed ID: 15753998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mode of action of estra-1,3,5(10)-triene-3, 17 beta-diol, 3-benzoate, 17[4-[4-[bis(2-chloroethyl)amino]phenyl]-1-oxobutoxy] acetate] (KM2210) on MCF-7 human breast tumours transplanted into nude mice.
    Kubota T; Ishibiki K; Abe O; Kosano H; Ohsawa N; Hoffman RM
    Anticancer Res; 1993; 13(4):935-40. PubMed ID: 8352562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice.
    Yao K; Lee ES; Bentrem DJ; England G; Schafer JI; O'Regan RM; Jordan VC
    Clin Cancer Res; 2000 May; 6(5):2028-36. PubMed ID: 10815929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
    Swami S; Krishnan AV; Feldman D
    Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo growth regulation by cytokine in breast cancer cells showing an estradiol-inhibitive response in vitro.
    Matsuoka H; Tomisaki S; Ohno S; Ikejiri K; Saku M; Shirasaka C; Ueo H; Sugimachi K
    Anticancer Res; 1997; 17(4A):2549-54. PubMed ID: 9252679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis.
    Johnston SR; Boeddinghaus IM; Riddler S; Haynes BP; Hardcastle IR; Rowlands M; Grimshaw R; Jarman M; Dowsett M
    Cancer Res; 1999 Aug; 59(15):3646-51. PubMed ID: 10446976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 4 inhibits growth and induces apoptosis in human breast cancer cells.
    Gooch JL; Lee AV; Yee D
    Cancer Res; 1998 Sep; 58(18):4199-205. PubMed ID: 9751635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel 5-aminoflavone derivatives as specific antitumor agents in breast cancer.
    Akama T; Shida Y; Sugaya T; Ishida H; Gomi K; Kasai M
    J Med Chem; 1996 Aug; 39(18):3461-9. PubMed ID: 8784443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bestrabacil: a possible target-oriented anticancer agent].
    Ohsawa N; Yamazaki Z; Wagatsuma T; Isurugi K
    Gan To Kagaku Ryoho; 1984 Oct; 11(10):2115-24. PubMed ID: 6548354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytostatic and cytotoxic action of Z-1, 1-dichloro-2,3-diphenylcyclopropane in three human breast cancer cell lines.
    ter Haar E; Day BW
    Anticancer Res; 1996; 16(3A):1107-15. PubMed ID: 8702221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapamycin inhibits proliferation of estrogen-receptor-positive breast cancer cells.
    Chang SB; Miron P; Miron A; Iglehart JD
    J Surg Res; 2007 Mar; 138(1):37-44. PubMed ID: 17109887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histoculture drug response assay, a possible examination system for predicting the antitumor effect of aromatase inhibitors in patients with breast cancer.
    Nakamura J; Imai E; Yoshihama M; Sasano H; Kubota T
    Anticancer Res; 1998; 18(1A):125-8. PubMed ID: 9568066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoblast-derived growth factors enhance adriamycin-cytostasis of MCF-7 human breast cancer cells.
    Choki I; Sourla A; Reyes-Moreno C; Koutsilieris M
    Anticancer Res; 1998; 18(6A):4213-24. PubMed ID: 9891470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro estradiol-sensitivity characterization of the MCF-7, ZR-75, MDA-MB-231 and T47-D human breast neoplastic cell lines.
    Camby I; Kiss R
    Anticancer Res; 1993; 13(6A):2355-60. PubMed ID: 8297158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of statins combined with estradiol on the proliferation of human receptor-positive and receptor-negative breast cancer cells.
    Mueck AO; Seeger H; Wallwiener D
    Menopause; 2003; 10(4):332-6. PubMed ID: 12851516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A metastatic breast tumor cell line, GI-101A, is estrogen receptor positive and responsive to estrogen but resistant to tamoxifen.
    Morrissey JJ; Raney S
    Cell Biol Int; 1998; 22(6):413-9. PubMed ID: 10328849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study on the effects of estradiol and estramustine on gastrointestinal cell lines.
    Harrison JD; Watson S; Ellis IO; Morris DL
    Eur J Surg Oncol; 1990 Apr; 16(2):116-20. PubMed ID: 2182340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.